0001213900-22-008953.txt : 20220223 0001213900-22-008953.hdr.sgml : 20220223 20220223161838 ACCESSION NUMBER: 0001213900-22-008953 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220222 FILED AS OF DATE: 20220223 DATE AS OF CHANGE: 20220223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lefkowitz Steven W CENTRAL INDEX KEY: 0001313149 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34673 FILM NUMBER: 22663951 MAIL ADDRESS: STREET 1: SIX HARRISON STREET CITY: NEW YORK STATE: NY ZIP: 10013 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CorMedix Inc. CENTRAL INDEX KEY: 0001410098 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 CONNELL DRIVE STREET 2: SUITE 4200 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 908-517-9500 MAIL ADDRESS: STREET 1: 300 CONNELL DRIVE STREET 2: SUITE 4200 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 4 1 doc4.xml PRIMARY DOCUMENT X0306 4 2022-02-22 false 0001410098 CorMedix Inc. CRMD 0001313149 Lefkowitz Steven W C/O CORMEDIX INC. 300 CONNELL DRIVE, SUITE 4200 BERKELEY HEIGHTS 07922 true false false false Common Stock 60498.0000 D Common Stock 30152.0000 I Wade Capital Corp Money Purchase Plan Common Stock 2000.0000 I Reporting Person's Wife Stock Option (Right to Buy Common Stock) 4.0300 2022-02-22 4 A false 20000.0000 0.0000 A 2032-02-22 Common Stock 20000.0000 20000.0000 D Stock Option (Right to Buy Common Stock) 8.3200 2031-01-11 Common Stock 30000.0000 30000.0000 D Stock Option (Right to Buy Common Stock) 5.6300 2030-02-25 Common Stock 15000.0000 15000.0000 D Stock Option (Right to Buy Common Stock) 8.3000 2029-01-10 Common Stock 15000.0000 15000.0000 D Stock Option (Right to Buy Common Stock) 2.8500 2028-02-16 Common Stock 8000.0000 8000.0000 D Stock Option (Right to Buy Common Stock) 2.2500 2027-06-25 Common Stock 15000.0000 15000.0000 D The reporting person beneficially owns these securities through Wade Capital Corporation Money Purchase Plan (an entity for which he has voting and investment control). These options were granted on 1/11/2021. These options are fully vested. These options were granted on 02/25/2020. These options are fully vested. These options were granted on 01/10/2019. The options are fully vested. These options were granted on 2/16/2018. These options are fully vested. These options were granted on 6/25/2017. These options are fully vested. These options were granted on 2/22/2022. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split. /s/ Steven W Lefkowitz 2022-02-23